The evolving understanding of risk with calcitonin gene‐related peptide monoclonal antibodies based on real‐world data: A focus on hypertension and Raynaud phenomenon

PERSPECTIVES The evolving understanding of risk with calcitonin gene-related peptide monoclonal antibodies based on real-world data: A focus on hypertension and Raynaud phenomenon Ilana D. Breen BS, Mayo Clinic Alix School of Medicine, Scottsdale, AZ, USASearch for more papers by this authorAaron R. Mangold MD, Dermatology, Mayo Clinic Arizona, Scottsdale, AZ, USASearch for more papers by this authorJuliana H. VanderPluym MD, Corresponding...